Note 16 - Stock-based Compensation - Stock Options (Details) $ / shares in Units, $ in Thousands |
6 Months Ended | |
|---|---|---|
|
Jun. 30, 2026
USD ($)
$ / shares
shares
|
Dec. 31, 2025
USD ($)
|
|
| Balance, options (in shares) | shares | 265,000 | |
| Outstanding, options, weighted average exercise price (in dollars per share) | $ / shares | $ 10 | |
| Outstanding, options, intrinsic value | $ | $ 0 | $ 914 |
| Granted, options (in shares) | shares | 600,000 | |
| Granted options, weighted average exercise price (in dollars per share) | $ / shares | $ 25 | |
| Balance, options (in shares) | shares | 865,000 | |
| Outstanding, options, weighted average exercise price (in dollars per share) | $ / shares | $ 20.4 | |
| Outstanding, options, remaining contractual term (Year) | 9 years 3 months 18 days | |
| Exercisable, options (in shares) | shares | 406,000 | |
| Exercisable, options, weighted average exercise price (in dollars per share) | $ / shares | $ 19.85 | |
| Exercisable, options, intrinsic value | $ | $ 0 |
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|